Furthermore, a subgroup of individuals with MASLD presented a lipid-induced impairment of hepatic sensitivity, not only to insulin but also to glucagon, resulting in both hyperglucagonemia and hyperinsulinemia [66,67]. The gene discussed is GCG; the disease is Hyperinsulinemia.